Long-Term Evolocumab Safe and Effective for Treating Hypercholesterolemia
Pridané:
27.2.2019
Autori:
Koren MJ, Sabatine MS, Giugliano RP, et al. Final report of the OSLER-1 study: long-term evolocumab for the treatment of hypercholesterolemia *** Presented at: AHA 2018; November 10-12, 2018; Chicago, Illinois. Abstract 118